126 related articles for article (PubMed ID: 2151200)
1. Hypolipidemic activity of benzohydroxamic acids and dibenzohydroxamic acids in rodents.
Izydore RA; Debnath ML; Woodard T; Wong OT; Hall IH
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):307-21. PubMed ID: 2151200
[TBL] [Abstract][Full Text] [Related]
2. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
Hall IH; Wong OT; Simlot R; Izydore RA
Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
[TBL] [Abstract][Full Text] [Related]
3. Hypolipidemic activity of aliphatic dicarboxylic acids in rodents.
Izydore RA; Hall IH
Acta Pharm Nord; 1991; 3(3):141-6. PubMed ID: 1793508
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidemic activity of some hydropolyborate salts in rodents.
Hall IH; Brotherton RJ; Docks EL; Griffin TS; Sood A; Spielvogel BF
Biomed Biochim Acta; 1991; 50(8):1007-17. PubMed ID: 1781772
[TBL] [Abstract][Full Text] [Related]
5. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH
Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485
[TBL] [Abstract][Full Text] [Related]
6. The effects on lipid metabolism of 4-phenyl-5,5-dicarbethoxy-2-pyrrolidenone in Sprague Dawley rats.
Hall IH; Wong OT; Reynolds DJ; Chang JJ
Acta Pharm Nord; 1992; 4(3):179-86. PubMed ID: 1329835
[TBL] [Abstract][Full Text] [Related]
7. Effect of Garcinia cambogia extract on lipids and lipoprotein composition in dexamethasone administered rats.
Mahendran P; Devi CS
Indian J Physiol Pharmacol; 2001 Jul; 45(3):345-50. PubMed ID: 11881574
[TBL] [Abstract][Full Text] [Related]
8. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Huang Y; Hall IH
Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737
[TBL] [Abstract][Full Text] [Related]
10. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH
Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157
[TBL] [Abstract][Full Text] [Related]
11. Hypolipidemic activity of a series of N-pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimides in rodents.
Hall IH; Wong OT; Futch G; Scovill JP
Biomed Biochim Acta; 1990; 49(1):103-13. PubMed ID: 2360899
[TBL] [Abstract][Full Text] [Related]
12. Preventive effect of S-allyl cysteine sulfoxide (alliin) on cardiac marker enzymes and lipids in isoproterenol-induced myocardial injury.
Sangeetha T; Darlin Quine S
J Pharm Pharmacol; 2006 May; 58(5):617-23. PubMed ID: 16640830
[TBL] [Abstract][Full Text] [Related]
13. Hypolipidemic activity in rodents of phenobarbital and related derivatives.
Hall IH; Patrick MA; Maguire JH
Arch Pharm (Weinheim); 1990 Sep; 323(9):579-86. PubMed ID: 2288480
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
15. Hypolipidemic activity of 4-substituted 1,2-diacyl-1,2,4-triazolidine-3,5-diones in rodents.
Simlot R; Izydore RA; Wong OT; Hall IH
J Pharm Sci; 1994 Mar; 83(3):367-71. PubMed ID: 8207683
[TBL] [Abstract][Full Text] [Related]
16. Effects of 2,3-dihydrophthalazine-1,4-dione on Sprague Dawley rats lipid metabolism and serum lipoproteins.
Hall IH; Wong OT; Reynolds DJ; Oswald CB
Biomed Biochim Acta; 1988; 47(4-5):423-33. PubMed ID: 3240293
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the S(+) and R(-) enantiomers of 5-ethyl-5-phenylhydantoin as hypolipidemic agents in rodents.
Hall IH; Maguire JH; Wong OT; Day PA; Alpin RS
Biomed Biochim Acta; 1987; 46(7):623-34. PubMed ID: 3426573
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the hypolipidemic effects of coconut water and lovastatin in rats fed fat-cholesterol enriched diet.
Sandhya VG; Rajamohan T
Food Chem Toxicol; 2008 Dec; 46(12):3586-92. PubMed ID: 18809454
[TBL] [Abstract][Full Text] [Related]
19. [The behavior of lipoproteins, cholesterol, triglycerides, free fatty acids and free glycerol in serum of rats with experimental hyperthyroxinemia and hypothyreosis].
Hübner G; Renner K; Rauer G
Endokrinologie; 1976 Mar; 67(1):60-6. PubMed ID: 1244201
[TBL] [Abstract][Full Text] [Related]
20. Hypolipidemic activity of 6-alkoxycarbonyl-3-aryl-1,3,5- triazabicyclo[3.1.0]hexane-2,4-diones and 2-alkoxycarbonyl-5-aryl-1,3,5-triazine-4,6(1H,5H)-diones in rodents.
Izydore RA; Wong OT; Hall IH
Lipids; 1993 Mar; 28(3):223-9. PubMed ID: 8464353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
